Professor Inger Sandlie is engaged at the Albumedix' Scientific Advisory Board
Oct. 19, 2017 12:14 PM
Professor Inger Sandlie is engaged to be part of the Scientifc Advisory Board at Albumedix' R&D organization, to provide governance and advice as it builds and develops its pipeline of proprietary and differentiated drugs.
Dr. Med. Peter Szodoray appointed Honorary Professor of the University of Debrecen
Oct. 12, 2017 1:57 PM
CIR scientist Dr. Med. Peter Szodoray was recently appointed Honorary Professor of the University of Debrecen, Hungary
Albumedix has signed research agreement with OUS and UiO on CIR research
Sep. 29, 2017 2:39 PM
In a press release, the pharmaceutical company Albumedix (Copenhagen, Denmark) has announced that it has signed a strategic research agreement with Oslo University Hospital and University of Oslo. The three organisations will work together to improve understanding of the interaction between bioengineered albumin variants and the neonatal Fc receptor (FcRn).
CIR publication by Bishnudeo Roy and colleagues highlighted in The Journal of Immunology
Aug. 16, 2017 3:20 PM
The article "High-Throughput Single-Cell Analysis of B Cell Receptor Usage among Autoantigen-Specific Plasma Cells in Celiac Disease" in the July 15, 2017 issue of The Journal of Immunology is being featured by the “In This Issue" section.
CIR annual report 2016
June 28, 2017 4:37 PM
The annual report 2016 from the Centre for Immune Regulation is now ready.
Close-up interview of Inger Sandlie in Titan
May 24, 2017 8:29 AM
Inger Sandlie - "The Tireless Inventor"